Jpmorgan Chase & CO Synlogic, Inc. Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.42 - $0.68 $176 - $285	-420 Reduced 95.67%	19 $0
Q1 2023 May 11, 2023	SELL	$0.56 - $1.07 $16 - $31	-29 Reduced 6.2%	439 $0
Q4 2022 Feb 13, 2023	BUY	$0.58 - $17.99 $260 - $8,077	449 Added 2363.16%	468 $0
Q3 2021 Nov 12, 2021	BUY	$2.45 - $4.1 $46 - $77	19 New	19 $0

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $105M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.